Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Rohin K Iyer"'
Autor:
Seul Lee, Yunjoo Joo, Eun Ji Lee, Youngseon Byeon, Jae-Hwan Kim, Kyoung-Ho Pyo, Young Seob Kim, Sun Min Lim, Peter Kilbride, Rohin K Iyer, Mingming Li, Mandy C French, Jung-Yub Lee, Jeeheon Kang, Hyesin Byun, Byoung Chul Cho
Publikováno v:
PLoS ONE, Vol 19, Iss 2, p e0294857 (2024)
Natural killer (NK) cells have recently shown renewed promise as therapeutic cells for use in treating hematologic cancer indications. Despite this promise, NK cell manufacturing workflows remain largely manual, open, and disconnected, and depend on
Externí odkaz:
https://doaj.org/article/f53e29796dd1462dbf5dea557ec090d1
Autor:
Rohin K Iyer, Venkat Venkataramanan, Grant N Pierce, Nikita Thakkar, Valle Natarajan, Arun Chockalingam
Publikováno v:
International Journal of Noncommunicable Diseases, Vol 6, Iss 5, Pp 19-28 (2021)
This white paper summarizes the key outcomes, topics, and recommendations from the Canada-India Healthcare Summit 2021 Conference, Biotechnology Session, held on May 20–21, 2021. In particular, the authors have focused their attention on topics ran
Externí odkaz:
https://doaj.org/article/e44b323f204b4bedaded97f7e9f9dbe4
Publikováno v:
Frontiers in Medicine, Vol 5 (2018)
Cell therapy has proven to be a burgeoning field of investigation, evidenced by hundreds of clinical trials being conducted worldwide across a variety of cell types and indications. Many cell therapies have been shown to be efficacious in humans, suc
Externí odkaz:
https://doaj.org/article/d9624695b4474d3c86cf4f5ed1a7b13d
Autor:
Nikita Thakkar, Arun Chockalingam, Rohin K Iyer, Grant N. Pierce, Venkat Venkataramanan, Valle Natarajan
Publikováno v:
International Journal of Noncommunicable Diseases, Vol 6, Iss 5, Pp 19-28 (2021)
This white paper summarizes the key outcomes, topics, and recommendations from the Canada-India Healthcare Summit 2021 Conference, Biotechnology Session, held on May 20–21, 2021. In particular, the authors have focused their attention on topics ran
Autor:
Richart W Harper, Paul C. Goodwin, Mei S. Yamaguchi, Susan E. Ebeler, Angela L. Linderholm, Nicholas J. Kenyon, Paul A. Bowles, Yarden S. Gratch, Cristina E. Davis, Michael Schivo, Rohin K. Iyer, Mitchell M. McCartney
Publikováno v:
J Breath Res
Journal of breath research, vol 14, iss 1
Journal of breath research, vol 14, iss 1
Volatile organic compound (VOC) emissions were measured from Chinese Hamster Ovary (CHO) cell and T cell bioreactor gas exhaust lines with the goal of non-invasively metabolically profiling the expansion process. Measurements of cellular 'breath' wer
Autor:
David M. Hwang, Thomas K. Waddell, Akihiro Ohsumi, R. Coutinho, Shaf Keshavjee, John E. Davies, Pierre Mordant, Tereza Martinu, M. Pipkin, Stephen C. Juvet, Tomohito Saito, Manyin Chen, L. Caldarone, Marcelo Cypel, Mingyao Liu, Y. Watanabe, T. Kanou, Rohin K. Iyer, D. Nakajima, Ryan Lam
Publikováno v:
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 38(11)
BACKGROUND The application of mesenchymal stromal cell (MSC)–based therapy during ex vivo lung perfusion (EVLP) could repair injured donor lungs before transplantation. The aim of this study was to determine the efficacy of MSC therapy performed du
Autor:
Thomas K. Waddell, R. Coutinho, Pierre Mordant, Ilker Iskender, John E. Davies, L. Maahs, Rohin K. Iyer, Marcelo Cypel, Mingyao Liu, D. Nakajima, P. Behrens, R. Kalaf, Shaf Keshavjee
Publikováno v:
The Journal of Heart and Lung Transplantation. 35:1245-1254
Background Ex vivo lung perfusion (EVLP) presents a unique therapeutic opportunity to administer mesenchymal stromal cells (MSCs) to lung grafts before transplantation. We sought to determine the optimal route and dose of viable human umbilical cord
Autor:
S. Loo-Yong-Kee, Rohin K. Iyer, Yarden S. Gratch, Paul A. Bowles, Aaron Dulgar-Tulloch, R. Krishnan
Publikováno v:
Cytotherapy. 20:e8-e9
Publikováno v:
Current Opinion in Biotechnology. 22:706-714
Cardiac tissue engineering offers the promise of creating functional tissue replacements for use in the failing heart or for in vitro drug screening. The last decade has seen a great deal of progress in this field with new advances in interdisciplina
Autor:
Milica Radisic, Rohin K. Iyer, C. Katherine Chiang, William L. Stanford, Mohammad Fahad Chowdhury
Publikováno v:
Acta Biomaterialia. 6:1904-1916
Differentiation of stem and progenitor cells routinely relies on the application of soluble growth factors, an approach that enables temporal control of cell fate but enables no spatial control of the differentiation process. Angiogenic progenitor ce